뒤로
Thermogenesis Holdings Inc(THMO) 가격
THMO 주가 차트
THMO 수입
Thermogenesis Holdings Inc
$0
0%
$0
종가: Feb 12, 16:00:00 GMT-5
$0
0%
$0
애프터마켓: Feb 12, 20:06:57 GMT-5
최신 수익 결과: Q1 '24
보고됨: 2024-05-17
역사적 수익
분기별
연간
EPS
수익
Earnings FAQ
THMO의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
Thermogenesis Holdings Inc THMO의 지난 분기 매출 실적은 어땠나요?
Thermogenesis Holdings Inc의 매출 추정치는 얼마인가요?
Thermogenesis Holdings Inc의 수익 품질 점수는 얼마인가요?
Thermogenesis Holdings Inc는 언제 수익을 보고하나요?
Thermogenesis Holdings Inc의 예상 수익은 얼마인가요?
Thermogenesis Holdings Inc은 수익 기대치를 충족했나요?
주요 통계
이전 종가
$0.0001
시가
$0.0001
일일 범위
$0.0001 - $0.0001
52주 범위
$0.0001 - $0.0003
거래량
331
평균 거래량
396
EPS(TTM)
-5.00
배당수익률
--
시가총액
$1.5K
THMO란 무엇인가요?
ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. The company is headquartered in Rancho Cordova, California and currently employs 25 full-time employees. The firm provides the AutoXpress and BioArchive platforms for automated clinical bio-banking, the PXP platform for point-of-care cell-based therapies and X-Series products for cell processing services. Its product lines include Clinical Bio-Banking Applications, Point-of-Care Applications and Cell Processing. Its Clinical Bio-Banking Applications include AXP II Automated Cell Separation System and BioArchive Automated Cryopreservation System. Its Point-of-Care Applications include PXP Point-of-Care System, and PXP-1000 System. Its Cell Processing includes X-Series Products for general laboratory use: X-Lab for cell isolation, X-Wash System for cell washing and reformulation, and X-Mini for high efficiency small scale cell purification. The firm markets and sells its medical device products through independent distributors.